Proteasomal degradation of the histone acetyl transferase p300 contributes to beta-cell injury in a diabetes environment.

Détails

Ressource 1Télécharger: 29789539_BIB_07427F5B73A3.pdf (1398.43 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_07427F5B73A3
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Proteasomal degradation of the histone acetyl transferase p300 contributes to beta-cell injury in a diabetes environment.
Périodique
Cell death & disease
Auteur⸱e⸱s
Ruiz L., Gurlo T., Ravier M.A., Wojtusciszyn A., Mathieu J., Brown M.R., Broca C., Bertrand G., Butler P.C., Matveyenko A.V., Dalle S., Costes S.
ISSN
2041-4889 (Electronic)
Statut éditorial
Publié
Date de publication
22/05/2018
Peer-reviewed
Oui
Volume
9
Numéro
6
Pages
600
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Résumé
In type 2 diabetes, amyloid oligomers, chronic hyperglycemia, lipotoxicity, and pro-inflammatory cytokines are detrimental to beta-cells, causing apoptosis and impaired insulin secretion. The histone acetyl transferase p300, involved in remodeling of chromatin structure by epigenetic mechanisms, is a key ubiquitous activator of the transcriptional machinery. In this study, we report that loss of p300 acetyl transferase activity and expression leads to beta-cell apoptosis, and most importantly, that stress situations known to be associated with diabetes alter p300 levels and functional integrity. We found that proteasomal degradation is the mechanism subserving p300 loss in beta-cells exposed to hyperglycemia or pro-inflammatory cytokines. We also report that melatonin, a hormone produced in the pineal gland and known to play key roles in beta-cell health, preserves p300 levels altered by these toxic conditions. Collectively, these data imply an important role for p300 in the pathophysiology of diabetes.
Mots-clé
Acetylation, Animals, Apoptosis/drug effects, Cytokines/metabolism, Diabetes Mellitus/enzymology, Diabetes Mellitus/pathology, E1A-Associated p300 Protein/genetics, E1A-Associated p300 Protein/metabolism, Glucose/toxicity, Histones/metabolism, Humans, Inflammation Mediators/metabolism, Insulin-Secreting Cells/drug effects, Insulin-Secreting Cells/enzymology, Insulin-Secreting Cells/pathology, Male, Melatonin/metabolism, Mice, Inbred C57BL, Proteasome Endopeptidase Complex/metabolism, Proteolysis/drug effects, RNA, Messenger/genetics, RNA, Messenger/metabolism, Receptors, Melatonin/metabolism, Signal Transduction
Pubmed
Web of science
Open Access
Oui
Création de la notice
14/06/2021 9:59
Dernière modification de la notice
25/05/2024 7:13
Données d'usage